Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism

Journal of Cell Science

Volumn 126, Issue 23, 2013, Pages 5432-5440

  Bozec, Aline ^a,b   Bakiri, Latifa ^a   Jimenez, Maria ^a   Rosen, Evan D ^c   Catalá Lehnen, Philip ^d   Schinke, Thorsten ^d   Schett, Georg ^b   Amling, Michael ^d   Wagner, Erwin F ^a  

^a BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Activator protein 1; Adiponectin; AP 1; Fosl2; Fra 2; Metabolism; Osteoblasts; Osteocalcin

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; BONE MASS; CARTILAGE CELL; CELL COUNT; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HOMEOSTASIS; IN VITRO STUDY; INSULIN METABOLISM; INSULIN SENSITIVITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ACTIVATOR PROTEIN 1; ADIPONECTIN; AP-1; FOSL2; FRA-2; METABOLISM; OSTEOBLASTS; OSTEOCALCIN;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; FOS-RELATED ANTIGEN-2; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; INSULIN; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; SIGNAL TRANSDUCTION; SKULL; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84890155229     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.134510     Document Type: Article

References (41)

1. Bakiri, L., Matsuo, K., Wisniewska, M., Wagner, E. F. and Yaniv, M. (2002). Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22, 4952-4964.
2. Beard, C., Hochedlinger, K., Plath, K., Wutz, A. and Jaenisch, R. (2006). Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44, 23-28.
3. Berner, H. S., Lyngstadaas, S. P., Spahr, A., Monjo, M., Thommesen, L., Drevon, C. A., Syversen, U. and Reseland, J. E. (2004). Adiponectin and its receptors are expressed in bone-forming cells. Bone 35, 842-849.
4. Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., Scheuch, H., Priemel, M., Stewart, C. L., Amling, M. et al. (2008). Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 454, 221-225.
5. Bozec, A., Bakiri, L., Jimenez, M., Schinke, T., Amling, M. and Wagner, E. F. (2010). Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J. Cell Biol. 190, 1093-1106.
6. Ealey, K. N., Kaludjerovic, J., Archer, M. C. and Ward, W. E. (2008). Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp. Biol. Med. 233, 1546-1553.
7. Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M. and Wagner, E. F. (2004). The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789-2799.
8. Eferl, R., Zenz, R., Theussl, H. C. and Wagner, E. F. (2007). Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis 45, 447-451.
9. Eferl, R., Hasselblatt, P., Rath, M., Popper, H., Zenz, R., Komnenovic, V., Idarraga, M. H., Kenner, L. and Wagner, E. F. (2008). Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc. Natl. Acad. Sci. USA 105, 10525-10530.
10. Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J., Estall, J. L., Klein, U., Maratos-Flier, E. and Rosen, E. D. (2011). Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 13, 249-259.
11. Engl, J., Bobbert, T., Ciardi, C., Laimer, M., Tatarczyk, T., Kaser, S., Weiss, H., Molnar, C., Tilg, H., Patsch, J. R. et al. (2007). Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity 15, 1172- 1178.
12. Ferron, M., Hinoi, E., Karsenty, G. and Ducy, P. (2008). Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105, 5266-5270.
13. Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P. and Karsenty, G. (2010). Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296-308.
14. Ferron, M., McKee, M. D., Levine, R. L., Ducy, P. and Karsenty, G. (2012). Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50, 568-575.
15. Grigoriadis, A. E., Schellander, K., Wang, Z. Q. and Wagner, E. F. (1993). Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122, 685-701.
16. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792.
17. Karreth, F., Hoebertz, A., Scheuch, H., Eferl, R. and Wagner, E. F. (2004). The AP1 transcription factor Fra2 is required for efficient cartilage development. Development 131, 5717-5725.
18. Karsenty, G. and Ferron, M. (2012). The contribution of bone to whole-organism physiology. Nature 481, 314-320.
19. Kawai, M., Devlin, M. J. and Rosen, C. J. (2009). Fat targets for skeletal health. Nat. Rev. Rheumatology 5, 365-372.
20. Kveiborg, M., Chiusaroli, R., Sims, N. A., Wu, M., Sabatakos, G., Horne, W. C. and Baron, R. (2002). The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology 143, 4304-4309.
21. Lee, N. K. and Karsenty, G. (2008). Reciprocal regulation of bone and energy metabolism. Trends Endocrinol. Metab.19, 161-166.
22. Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y. et al. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469.
23. Lee, H. W., Kim, S. Y., Kim, A. Y., Lee, E. J., Choi, J. Y. and Kim, J. B. (2009). Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27, 2254-2262.
24. Lefterova, M. I. and Lazar, M. A. (2009). New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114.
25. Luther, J., Driessler, F., Megges, M., Hess, A., Herbort, B., Mandic, V., Zaiss, M. M., Reichardt, A., Zech, C., Tuckermann, J. P. et al. (2011). Elevated Fra-1 expression causes severe lipodystrophy. J. Cell Sci. 124, 1465-1476.
26. Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H. and Shimomura, I. (2005). Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331, 520-526.
27. Oury, F., Sumara, G., Sumara, O., Ferron, M., Chang, H., Smith, C. E., Hermo, L., Suarez, S., Roth, B. L., Ducy, P. et al. (2011). Endocrine regulation of male fertility by the skeleton. Cell 144, 796-809.
28. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R.; Report of the ASBMR Histomorphometry Nomenclature Committee (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 2, 595-610.
29. Rached, M. T., Kode, A., Xu, L., Yoshikawa, Y., Paik, J. H., Depinho, R. A. and Kousteni, S. (2010). FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11, 147- 160.
30. Rodda, S. J. and McMahon, A. P. (2006). Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244.
31. Shetty, S., Kusminski, C. M. and Scherer, P. E. (2009). Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol. Sci. 30, 234-239.
32. Shinoda, Y., Yamaguchi, M., Ogata, N., Akune, T., Kubota, N., Yamauchi, T., Terauchi, Y., Kadowaki, T., Takeuchi, Y., Fukumoto, S. et al. (2006). Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell. Biochem. 99, 196-208.
33. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P. and Karsenty, G. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317.
34. Tilg, H. and Moschen, A. R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783.
35. Wagner, E. F. and Eferl, R. (2005). Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140.
36. Williams, G. A., Wang, Y., Callon, K. E., Watson, M., Lin, J. M., Lam, J. B., Costa, J. L., Orpe, A., Broom, N., Naot, D. et al. (2009). In vitro and in vivo effects of adiponectin on bone. Endocrinology 150, 3603-3610.
37. Wrann, C. D., Eguchi, J., Bozec, A., Xu, Z., Mikkelsen, T., Gimble, J., Nave, H., Wagner, E. F., Ong, S. E. and Rosen, E. D. (2012). FOSL2 promotes leptin gene expression in human and mouse adipocytes. J. Clin. Invest. 122, 1010-1021.
38. Yang, X. and Karsenty, G. (2004). ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279, 47109- 47114.
39. Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone-Corsi, P., Townes, T. M. et al. (2004). ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin- Lowry Syndrome. Cell 117, 387-398.
40. Yoshizawa, T., Hinoi, E., Jung, D. Y., Kajimura, D., Ferron, M., Seo, J., Graff, J. M., Kim, J. K. and Karsenty, G. (2009). The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119, 2807-2817.
41. Zhao, L. J., Jiang, H., Papasian, C. J., Maulik, D., Drees, B., Hamilton, J. and Deng, H. W. (2008). Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res. 23, 17-29.